Edwards Lifesciences
1,320 hedge funds and large institutions have $66.6B invested in Edwards Lifesciences in 2021 Q4 according to their latest regulatory filings, with 207 funds opening new positions, 461 increasing their positions, 417 reducing their positions, and 95 closing their positions.
118% more first-time investments, than exits
New positions opened: 207 | Existing positions closed: 95
29% more funds holding in top 10
Funds holding in top 10: 21 → 27 (+6)
15% more capital invested
Capital invested by funds: $58.1B → $66.6B (+$8.54B)
11% more repeat investments, than reductions
Existing positions increased: 461 | Existing positions reduced: 417
8% more funds holding
Funds holding: 1,227 → 1,320 (+93)
5% more call options, than puts
Call options by funds: $250M | Put options by funds: $239M
0.1% more ownership
Funds ownership: 82.42% → 82.53% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$467M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$297M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$256M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$179M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$146M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$573M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$328M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$261M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$132M |
| 5 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$121M |
EW Hedge Fund Activity: Q4 2021 in Review
1,320 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2021, worth a combined $66.6B — up 15% from $58.1B a quarter earlier.
Buyers outnumbered sellers: 207 funds opened new EW positions and 95 closed out — a net gain of 112 holders — while 461 added to existing stakes and 417 trimmed.
The largest buyer was BlackRock, adding an estimated $467M. The largest seller was Capital Research Global Investors, cutting an estimated $573M.
- 1,320 institutional investors held Edwards Lifesciences (EW) as of Q4 2021, up from 1,227 in Q3 2021.
- Funds reported $66.6B of Edwards Lifesciences stock for Q4 2021, up 15% quarter-over-quarter.
- 207 funds opened new Edwards Lifesciences positions in Q4 2021 and 95 closed out, a net change of +112 holders.
- The largest Edwards Lifesciences buyer in Q4 2021 was BlackRock, an estimated $467M added.
- The largest Edwards Lifesciences seller in Q4 2021 was Capital Research Global Investors, an estimated $573M sold.
Based on aggregated 13F filings for Q4 2021.